Inhibition of angiogenesis: Thalidomide or low-molecular-weight heparin? Authors' reply
Year: 2005
Type: letter
Source: Journal of Clinical Oncology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2589248314
